Filing Flows › Lucid Diagnostics (LUCD) › Q3 2025
Lucid Diagnostics (LUCD) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 12, 2025
Lucid Diagnostics (LUCD) reported revenue of $1.2M for the third quarter 2025 (Q3 2025), +3% from a year earlier and +4% from the quarter before. Operating margin was -971.0%, net loss $10.4M (858.5% of revenue).
Lucid Diagnostics, Q3 2025: revenue $1.2M (+3% year over year), operating margin -971.0%, net loss $10.4M, operating cash flow −$10.9M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | +4% | +3% |
| Operating profit | −$11.8M | — | — |
| Net earnings | −$10.4M | — | — |
| Operating cash flow | −$10.9M | — | — |
What changed
Revenue was $1.2M in Q3 2025, up 3% year over year and up 4% from the previous quarter.
Operating costs exceeded revenue by $11.8M, an operating margin of -971.0%. Total costs grew 1% against revenue growth of 3%. The quarter ended with a net loss of $10.4M, wider than the previous quarter's $4.4M loss.
Operating cash flow was −$10.9M. Non-cash charges added back $220K of depreciation and amortization and $1.1M of share-based compensation. Working capital and other items used $1.9M. Capital expenditures of $28K exceeded it, leaving free cash flow of −$10.9M.
Questions
What was Lucid Diagnostics' revenue in the third quarter 2025?
Lucid Diagnostics (LUCD) reported revenue of $1.2M for the third quarter 2025 (Q3 2025), +3% from a year earlier and +4% from the quarter before.
Was Lucid Diagnostics profitable in the third quarter 2025?
Operating loss was $11.8M (-971.0% of revenue) and net loss $10.4M.
Source: Lucid Diagnostics 10-Q on SEC EDGAR.